Literature DB >> 19643257

Analysis of residual symptoms after treatment in benign paroxysmal positional vertigo using questionnaire.

No Hee Lee1, Hee Jun Kwon, Jae Ho Ban.   

Abstract

OBJECTIVES: Canalith repositioning procedure (CRP) provides rapid and long-lasting relief of symptoms in most patients with benign paroxysmal positional vertigo. However, some patients express nonspecific symptoms such as anxiety or discomfort after treatment, even after the disappearance of nystagmus and vertigo. The purpose of this study was to assess the residual symptoms after CRP in patients with benign paroxysmal positional vertigo using the Dizziness Handicap Inventory (DHI) in a questionnaire format. STUDY DESIGN AND
SETTING: Controlled, prospective study. SUBJECTS AND METHODS: CRP was performed in 135 patients until nystagmus and vertigo disappeared. Patients were asked to complete the questionnaire before and 5 to 7 days after treatment. A control group of 135 normal volunteers was selected and cross-matched according to the age and sex of the patient group. The data were compared for the pre-CRP, post-CRP, and control groups.
RESULTS: There was a significant improvement in the DHI scores when comparing the pre- and post-CRP groups (P=0.000), although six items showed incomplete improvement. Subsequent comparison of DHI scores between the control group and the post-CRP group still showed a difference in some items so that the improvement was incomplete.
CONCLUSION: Even after successful CRPs, Dizziness Handicap Inventory scores indicated that residual subjective symptoms may remain. Thus, additional follow-up and management are important for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19643257     DOI: 10.1016/j.otohns.2009.04.006

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Residual dizziness after the first BPPV episode: role of otolithic function and of a delayed diagnosis.

Authors:  Mario Faralli; Ruggero Lapenna; Giorgia Giommetti; Cristina Pellegrino; Giampietro Ricci
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

2.  The impact of diabetes on mobility, balance, and recovery after repositioning maneuvers in individuals with benign paroxysmal positional vertigo.

Authors:  Linda J D'Silva; Susan L Whitney; Marcio Santos; Hongying Dai; Patricia M Kluding
Journal:  J Diabetes Complications       Date:  2017-03-22       Impact factor: 2.852

Review 3.  Risk factors for residual dizziness in patients with benign paroxysmal positional vertigo after successful repositioning: a systematic review and meta-analysis.

Authors:  Yujie Ke; Xin Ma; Yuanyuan Jing; Tongxiang Diao; Lisheng Yu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-26       Impact factor: 2.503

4.  Treatment of horizontal canal BPPV-a randomized sham-controlled trial comparing two therapeutic maneuvers of different speeds.

Authors:  Camilla Martens; Frederik Kragerud Goplen; Torbjørn Aasen; Rolf Gjestad; Karl Fredrik Nordfalk; Stein Helge Glad Nordahl
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-29

5.  Clinical and cVEMP Evaluation Predict Short-Term Residual Dizziness After Successful Repositioning in Benign Paroxysmal Positional Vertigo.

Authors:  Chun-Yan Jiang; Jing Wu; Liang Shu; Xu-Hong Sun; Hui Pan; Qian Xu; Si-Cheng Wu; Jian-Ren Liu; Yun Li; Wei Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-24

Review 6.  Residual Dizziness after Successful Repositioning Maneuver for Idiopathic Benign Paroxysmal Positional Vertigo: A Review.

Authors:  Giorgia Giommetti; Ruggero Lapenna; Roberto Panichi; Puya Dehgani Mobaraki; Fabrizio Longari; Giampietro Ricci; Mario Faralli
Journal:  Audiol Res       Date:  2017-05-09

7.  Active Head Auto-Rotations in Patients With Benign Paroxysmal Positional Vertigo.

Authors:  Sertac Yetiser; Dilay Ince
Journal:  J Clin Med Res       Date:  2021-02-25

8.  Efficacy of Repositioning Therapy in Patients With Benign Paroxysmal Positional Vertigo and Preexisting Central Neurologic Disorders.

Authors:  Chih-Chung Chen; Hsiao-Shan Cho; Hsun-Hua Lee; Chaur-Jong Hu
Journal:  Front Neurol       Date:  2018-06-29       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.